Founded in 1985 and based in New York, amfAR has invested nearly $290 million in its mission, funding over 2,000 research teams worldwide. Through its support of AIDS research, HIV prevention, treatment, education, and advocacy, amfAR has played a catalytic role in advancing our understanding of HIV and achieving breakthroughs in its study and treatment.